XOMA Royalty Corporation (XOMAP)
$24.98+0.00%Close
SELLBEAR · day 59
Key stats
- Market cap
- $301M
- Beta
- 0.86
- Div yield
- 6.47%
- P/E (TTM)
- 15.14
- 1W
- +0.00%
- 1M
- +0.36%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -2.63%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on XOMAP?
- LOPJLB’s latest quantitative signal on XOMA Royalty Corporation (XOMAP) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is XOMAP in?
- XOMA Royalty Corporation (XOMAP) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does XOMA Royalty Corporation (XOMAP) do?
- XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with …